Year | Volume (Price x Shares) | Change |
---|---|---|
2024 | $8.44 M | -92.18% |
2023 | $0.10 B | 60.05% |
2022 | $67.43 M | 90.89% |
2021 | $35.32 M | -76.42% |
2020 | $0.14 B | 197.63% |
2019 | $50.34 M | -29.09% |
2018 | $70.99 M | 835.37% |
2017 | $7.59 M | 22.08% |
2016 | $6.21 M | -19.68% |
2015 | $7.74 M | -7.23% |
2014 | $8.34 M | 721.71% |
2013 | $1.01 M |
Company | FTD volume (3months) | FTD volume (1 year) | Country |
---|---|---|---|
Pfizer PFE | $31.87 M | $0.32 B | ๐บ๐ธ USA |
Thermo Fisher Scientific TMO | $0.18 B | $0.40 B | ๐บ๐ธ USA |
General Electric GE | $0.64 B | $0.88 B | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $0.19 B | $0.29 B | ๐บ๐ธ USA |
Sangamo Therapeutics
SGMO | $0.14 M | $1.62 M | ๐บ๐ธ USA |
Novavax NVAX | $39.62 M | $0.34 B | ๐บ๐ธ USA |
Neurocrine Biosciences
NBIX | $15.59 M | $35.11 M | ๐บ๐ธ USA |
Bio-Techne TECH | $11.64 M | $29.73 M | ๐บ๐ธ USA |
BioMarin Pharmaceutical BMRN | $2.19 M | $7.77 M | ๐บ๐ธ USA |
Charles River Laboratories
CRL | $5.5 M | $20.68 M | ๐บ๐ธ USA |